Enhancing Participant-Centered Clinical Trials

The 2026 MDA Conference was an inspiring gathering for everyone involved in muscular dystrophy research: sponsors, CROs, patient advocacy groups, and participants themselves. It was a unique opportunity to see the innovative work in neuromuscular diseases and to understand the real-world challenges that participants face in clinical trials.

Prioritizing Participant-Centered Clinical Trials

One of the most impactful aspects of the conference was engaging directly with patient advocacy groups. Their insights highlighted how participant-focused site management solutions and tailor-made clinical trials can reduce participant burden while improving recruitment and retention.

Stories from participant s and caregivers emphasized the physical and emotional demands of assessments, travel, and frequent site visits, especially for conditions like Myotonic Dystrophy (DM1), Charcot-Marie-Tooth (CMT) Disease, and ALS.

A powerful example came from a sponsor conducting a DM1 trial: a young participant and their caregiver shared the difficulties of attending visits but expressed gratitude and motivation to participate due to access to potentially life-saving therapies. This underscores the importance for full-service CROs like Stiris Research to provide participant solutions that minimize burden and maximize engagement.

Innovative Approaches to Recruitment and Engagement

Several presentations focused on participant registries as a tool for clinical trial management. While registries can enhance recruitment, the conference highlighted the practical challenges of setting them up. Support for sites and physicians is essential to ensure accurate data collection and meaningful participation.

At Stiris Research, these insights reinforce the importance of combining site management, patient solutions, and clinical project management to provide a seamless and participant-friendly trial experience.

Effective strategies discussed included door-to-door participant transportation, timely reimbursements, and centralized information hubs. While new technologies are often promoted to streamline recruitment, the conference emphasized that straightforward, low-burden solutions are typically the most effective for participants.

Collaboration Between Academia and Industry

The conference highlighted the value of collaboration between academic researchers, sponsors, and CROs in designing efficient, participant-centered trials. Collecting feedback from both participant and physicians helps identify logistical challenges and refine study protocols.

Although discussions on data management, biostatistics, regulatory support, and medical monitoring were limited, the focus on patient experience remains a key differentiator for expert clinical trial management in a full-service CRO like Stiris Research.

Safety remains a top priority in all trials, with sponsors emphasizing medical monitoring and safety & pharmacovigilance practices to protect participants throughout the study.

The Power of Global Collaboration

The MDA conference reinforced a fundamental truth: without our patients, we cannot succeed. Reducing the burden on participants and caregivers, listening to their experiences, and providing clear, practical solutions is essential to advancing clinical trials.

Collaboration between participants, researchers, sponsors, and CROs like Stiris Research is critical for delivering patient-focused site management solutions, accelerating recruitment, and ultimately bringing life-changing treatments to those who need them most.

Key Takeaways

Lessons and Recommendations from the Conference:

• Minimizing participant burden: Focus on practical, straightforward solutions rather than complex technology to improve recruitment and participant satisfaction.
• Patient-centered trial design: Incorporate feedback from patients and caregivers to enhance both data quality and overall study experience.

Strengths Already in Practice at Stiris Research:

• Strong site relationships: Stiris Research builds reciprocal, trust-based partnerships with clinical sites, ensuring motivation, compliance, and successful enrollment.
• Full-service, tailored approach: The company provides expert clinical trial management, global and North American reach, and participant solutions across Phase I–IIIB studies in rare diseases, neuroscience, and other therapeutic areas.

By combining these lessons with existing strengths, Stiris Research continues to stand out as a full-service CRO capable of delivering participant-focused site management solutions and helping sponsors bring life-changing treatments to patients efficiently and effectively.